在接受高风险神经母细胞瘤治疗的儿童中长期甲状腺毒性负担
Annalisa Deodati1,2, Francesco Fabozzi3, Giulia Mirra1
1Endocrinology and Diabetes Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Thyroid : official journal of the American Thyroid Association
|February 24, 2026
概括
高风险神经母细胞瘤治疗显著增加了幸存者的长期甲状腺毒性风险. 持续的内分泌监测到成年期对于管理这些晚期影响至关重要.
科学领域:
- 儿科瘤学 儿科瘤学
- 内分泌学 在内分泌学.
- 癌症的生存率 癌症的生存率
背景情况:
- 高风险神经母细胞瘤 (HRNB) 的多式治疗改善了生存率,但可能导致长期内分泌问题.
- 由于密集治疗,甲状腺毒性是HRNB幸存者的一个重大问题.
研究的目的:
- 为了研究高风险神经母细胞瘤幸存者的长期甲状腺毒性.
- 为了确定与治疗后甲状腺功能障碍发展相关的危险因素.
主要方法:
- 在2023年6月1日活着的HRNB幸存者的回顾性,单中心队列研究.
- 在1996-2018年期间接受治疗的患者,诊断后至少5年的随访.
- 通过图表审查收集的数据来评估长期毒性风险因素.
主要成果:
- 在45名被评估的幸存者中,53%的人经历了长期的甲状腺毒性,最常见的是甲状腺功能低下症.
- 在10年内没有甲状腺毒性的概率为62%.
- 特定的治疗方法,如分子放射治疗,免疫治疗,协同骨髓退化化疗 (MAT) 和布苏尔法,与增加甲状腺毒性风险和早期发病有关.
结论:
- 在HRNB幸存者的累积治疗负担导致甲状腺毒性存在相当大的风险,治疗后多年持续.
- 长期内分泌随访,延伸到成年期,对于管理这些幸存者至关重要.
- 早期识别毒性风险因素可以为未来的治疗策略和幸存者护理提供信息.
更多相关视频
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.9K
06:08Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
2.4K
相关概念视频
Toxicity Testing in Animals
63
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
63
Drug Toxicity: Dose-Dependent Reactions
54
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
54
Drug Toxicity: Risk factors
55
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
55
